Inflammatory cytokine tumor necrosis factor-α enhances nerve growth factor production in human keratinocytes, HaCaT cells

Journal of Pharmacological Sciences

Volumn 111, Issue 4, 2009, Pages 381-391

  Takaoka, Koji ^a,b   Shirai, Yasuhito ^a   Saito, Naoaki ^a  

^a KOBE UNIVERSITY   (Japan)

^b DSR Corporation   (Japan)

Author keywords

Extracellular signal regulated kinase (ERK); Keratinocyte; Nerve growth factor (NGF); Signal transduction; Tumor necrosis factor (TNF)

Indexed keywords

EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; RAF PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; QUALITY OF LIFE; SENSORY NERVE; SKIN ALLERGY;

EID: 74849105588     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09143FP     Document Type: Article

References (54)

1. Lonne-Rhahm S, Berg M, Mårin P, Nordlind K. Atopic dermatitis, stinging, and effects of chronic stress: a pathocausal study. J Am Acad Dermatol. 2004;51:899-905.
2. Sugiura H, Omoto M, Hirota Y, Danno K, Uehara M. Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res. 1997;289:125-131.
3. Urashima R, Mihara M. Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch. 1998;432:363-370.
4. Tominaga M, Ozawa S, Ogawa H, Takamori K. A hypothetical mechanism of intraepidermal neurite formation in NC/Nga mice with atopic dermatitis. J Dermatol Sci. 2007;46:199-210.
5. Tominaga M, Ozawa S, Tengara S, Ogawa H, Takamori K. Intraepidermal nerve fibers increase in dry skin of acetone-treated mice. J Dermatol Sci. 2007;48:103-111.
6. Kinkelin I, Mötzing S, Koltzenburg M, Bröcker EB. Increase in NGF content and nerve fiber sprouting in human allergic contact aczema. Cell Tissue Res. 2000;302:31-37.
7. Tron VA, Coughlin MD, Jang DE, Stanisz J, Sauder DN. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J Clin Invest. 1990;85:1085-1089.
8. Pincelli C, Sevignani C, Manfredini R, Grande A, Fantini F, Bracci-Laudiero L, et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invet Dermatol. 1994;103:12-18.
9. Pincelli C, Marconi A. Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci. 2000;22:71-79.
10. Marconi A, Terracina M, Fila C, Franchi J, Bonté F, Romagnoli G, et al. Expression and function of neurotrophins and their receptors in cultured human keratinocytes. J Invest Dermatol. 2003;121:1515-1521.
11. Botchkarev VA, Yaar M, Peters EMJ, Raychaudhuli SP, Botchkareva NV, Marconi A, et al. Neurotrophins in skin biology and pathology. J Invest Dermatol. 2006;126:1718-1727.
12. Tanaka A, Matsuda H. Expression of nerve growth factor in itchy skins of atopic NC/NgaTnd mice. J Vet Med Sci. 2005;67:915-919.
13. Horiuchi Y, Bae S, Katayama I. Nerve growth factor (NGF) and epidermal nerve fibers in atopic dermatitis model NC/Nga mice. J Dermatol Sci. 2005;39:56-58.
14. Dou YC, Hagströmer L, Emtestam L, Johansson O. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study. Arch Dermatol Res. 2006;298:31-37.
15. Raychaudhuri SP, Jiang WY, Farber EM. Psoriatic keratinocytes express high level of nerve growth factor. Acta Derm Venereol. 1998;78:84-86.
16. Konstantinova NV, Lemak NA, Duvic M. Nerve growth factor in normal and psoriatic skin equivalent models. Arch Dermatol Res. 1998;290:610-614.
17. Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. Eur J Dermatol. 2000;10:85-90.
18. Nakamura M, Toyoda M, Morohashi M. Pruritogenic mediators in psoriasis vulgaris: comparative evaluation of itch-associated cutaneous factors. Br J Dermatol. 2003;149:718-730.
19. Saraceno R, Kleyn CE, Terenghi G, Griffiths CEM. The role of neuropeptides in psoriasis. Br J Dermatol. 2006;154:876-882.
20. Taniguchi M, Matsuzaki S, Tohyama M. P75 plays a key role in the induction of the sprouting of sensory nerve fibers in inflamed skin. J Invest Dermatol. 2007;127:2062-2065.
21. Nithya M, Suguna L, Rose C. The effect of nerve growth factor on the early responses during the process of wound healing. Biochem Biophys Acta. 2003;1620:25-31.
22. Pietrzak AT, Zalewska A, Chodorowska G, Krasowska D, Michalak-Stoma A, Nockowski P, et al. Cytokines and anticytokines in psoriasis. Clinica Chimica Acta. 2008;394:7-21.
23. Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008;214:149-160.
24. Sumimoto S, Kawai M, Kasajima Y, Hamamoto T. Increased plasma tumor necrosis factor-α concentration in atopic dermatitis. Arch Dis Child. 1992;67:277-279.
25. Kristensen M, Chu CQ, Eedy DJ, Feldmann M, Brennan FM, Breathnach SM. Localization of tumor necrosis factor-alpha (TNF-α) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol. 1993;94:354-362.
26. Ackermann L, Harvima IT, Pelkonen J, Ritamäki-Salo V, Naukkarinen A, Harvima RJ, et al. Mast cells in psoriatic skin are strongly positive for interferon-gamma. Br J Dermatol. 1999;140:624-633.
27. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A. 1989;86:6367-6371.
28. Kanda N, Watanabe S. Histamine enhances the production of nerve growth factor in human keratinocytes. J Invest Dermatol. 2003;121:570-577.
29. Hattori A, Tanaka E, Murase K, Ishida N, Chatani Y, Tsujimoto M, et al. Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells. J Biol Chem. 1993;268:2577-2582.
30. Hattori A, Iwasaki S, Murase K, Tsujimoto M, Sato M, Hayashi K, et al. Tumor necrosis factor is markedly synergistic with interleukin 1 and interferon-γ in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett. 1994;340:177-180.
31. Marco ED, Marchisio PC, Bondanza M, Franzi AT, Cancedda R, Luca MD. Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem. 1991;266:21718-21722.
32. Marco ED, Mathor M, Bondanza S, Cutuli N, Marchisio PC, Cancedda R, et al. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem. 1993;268:22838-22846.
33. Marconi A, Vaschieri C, Zanoli S, Giannetti A, Pincelli C. Nerve growth factor protects human keratinocytes from ultraviolet-B-induced apoptosis. J Invest Dermatol. 1999;113:920-927.
34. Kuno R, Yoshida Y, Nitta A, Nabeshima T, Wang J, Sonobe Y, et al. The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res. 2006;1116:12-18.
35. Hattori A, Hayashi K, Kohno M. Tumor necrosis factor (TNF) stimulates the production of nerve growth factor in fibroblasts via the 55-kDa type 1 TNF receptor. FEBS Lett. 1996;379:157-160.
36. Peeraully MR, Jenkins JR, Trayhurn P. NGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines. Am J Physiol Endocrinol Metab. 2004;287:331-339.
37. Kakurai M, Monteforte R, Suto H, Tsai M, Nakae S, Galli SJ. Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. Am J Pathol. 2006;169:1713-1721.
38. Müller G, Storz P, Bourteele S, Döppler H, Pfizenmaier K, Mischak H, et al. Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signaling. EMBO J. 1998;17:732-742.
39. Colangelo AM, Pani L, Mocchetti I. Correlation between increased AP-1NGF binding activity and induction of nerve growth factor transcription by multiple signal transduction pathways in C6-2B glioma cells. Mol Brain Res. 1996; 35:1-10.
40. Veenstra TD, Fahnestock M, Kumar R. An AP-1 site in the nerve growth factor promoter is essential for 1,25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts. Biochemistry. 1998;37:5988-5994.
41. Peng CH, Huang CN, Hsu SP, Wang CJ. Penta-acetyl geniposide-induced apoptosis involving transcription of NGF/p75 via MAPK-mediated AP-1 activation in C6 glioma cells. Toxicology. 2007;238:130-139.
42. Hengerer B, Lindholm D, Heumann R, Rüther U, Wagner EF, Thoenen H. Lesion-induced increase in nerve growth factor mRNA is mediated by c-Fos. Proc Natl Acad Sci U S A. 1990;87:3899-3903.
43. Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K, et al. A physical and functional map of the human TNFα/NFκB signal transduction pathway. Nat Cell Biol. 2004;6:97-105.
44. Beer HD, Gassmamm MG, Munz B, Steiling H, Engelhardt F, Bleuel K, et al. Expression and function of keratinocyte growth factor and activin in skin morphogenesis and cutaneous wound repair. J Invest Dermatol. 2000;5:34-39.
45. Keller U, Krampert M, Kümin A, Braun S, Werner S. Keratinocyte growth factor: effects on keratinocytes and mechanisms of action. Eur J Cell Biol. 2004;83:607-612.
46. Ray P. Protection of epithelial cells by keratinocyte growth factor signaling. Proc Am Thorac Soc. 2005;2:221-225.
47. Purwar R, Wittmann M, Zwirner J, Oppermann M, Kracht M, Dittrich-Breiholz O, et al. Induction of C3 and CCL2 by C3a in keratinocytes: a novel autocrine amplification loop of inflammatory skin reactions. J Immunol. 2006;177:4444-4450.
48. Nakano Y, Morita S, Kawamoto A, Suda T, Chida K, Nakamura H. Elevated complement C3a in plasma from patients with severe acute asthma. J Allergy Clin Immunol. 2003;112:525-530.
49. Kapp A, Wokalek H, Schopf E. Involvement of complement in psoriasis and atopic dermatitis - measurement of C3a and C5a, C3, C4 and C1 inactivator. Arch Dermatol Res. 1985;277:359-361.
50. Raychaudhuri SP, Sanyal M, Weltman H, Kundu-Raychaudhuri S. K252a, a high-affinity nerve growth factor receptor blocker, improves psoriasis: an in vivo study using the severe combined immunodeficient mouse-human skin model. J Invest Dermatol. 2004;122:812-819.
51. Takano N, Sakurai T, Ohashi Y, Kurachi M. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model. Br J Dermatol. 2006;156:241-246.
52. Takano N, Sakurai T, Kurachi M. Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. J Pharmacol Sci. 2005;99:277-286.
53. Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol. 2006;54:S67-S80.
54. Williams JDL, Griffiths CEM. Cytokine blocking agents in dermatology. Clin Exp Dermatol. 2002;27:585-590.